Tandem Diabetes Care (TNDM) EPS (Basic) (2013 - 2026)
Tandem Diabetes Care (TNDM) posted EPS (Basic) of -$0.3 for Q1 2026, down 3595.83% on a QoQ basis from -$0.01 in Q4 2025, and up 84.83% year-over-year from -$0.16 in Q1 2025.
Tandem Diabetes Care (TNDM) EPS (Basic) (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's EPS (Basic) history runs 14 years deep, the most recent figure standing at -$0.3 for Q1 2026.
- Quarterly EPS (Basic) rose 84.83% year-over-year to -$0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.38 (up 50.09% YoY) and the FY2025 annual result came in at -$3.04, down 107.37% from the prior year.
- EPS (Basic) was -$0.3 for Q1 2026 at Tandem Diabetes Care, down from -$0.01 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.01 in Q4 2024 and bottomed at -$1.97 in Q1 2025.
- A 5-year average of -$0.57 and a median of -$0.46 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 937.7% — and 2024, when it jumped 102.5%.
- Tandem Diabetes Care's EPS (Basic) stood at -$0.25 in 2022, then tumbled by 86.19% to -$0.46 in 2023, then soared by 102.5% to $0.01 in 2024, then slumped by 169.96% to -$0.01 in 2025, then plunged by 3595.83% to -$0.3 in 2026.
- Business Quant data shows TNDM's EPS (Basic) at -$0.3 in Q1 2026, -$0.01 in Q4 2025, and -$0.31 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.78 |
| Mar 31, 2025 | -1.97 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.47 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -0.55 |
| Mar 31, 2023 | -1.92 |
| Dec 31, 2022 | -0.25 |
| Sep 30, 2022 | -0.76 |
| Jun 30, 2022 | -0.23 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | 0.17 |
| Sep 30, 2021 | 0.09 |
| Jun 30, 2021 | 0.06 |